Centessa Pharmaceuticals Plc ADR (CNTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 0 | 0 | 15,000 | 0 | 0 |
| Gross Profit | N/A | N/A | 15,000 | N/A | N/A |
| Operating Expenses | 53,790 | 54,653 | 45,777 | 74,580 | 46,405 |
| Operating Income | -53,790 | -54,653 | -30,777 | -74,580 | -46,405 |
| Interest Expense | 2,890 | 2,884 | 2,877 | 2,479 | 2,557 |
| Other Income | 1,955 | 7,972 | 8,916 | -33,220 | 7,004 |
| Pre-tax Income | -54,725 | -49,565 | -24,738 | -110,279 | -41,958 |
| Income Tax | 166 | 778 | 1,397 | 1,050 | 608 |
| Net Income Continuous | -54,891 | -50,343 | -26,135 | -111,329 | -42,566 |
| Net Income | $-54,891 | $-50,343 | $-26,135 | $-111,329 | $-42,566 |
| EPS Basic Total Ops | -0.41 | -0.38 | -0.20 | -0.91 | -0.37 |
| EPS Basic Continuous Ops | -0.41 | -0.38 | -0.20 | -0.91 | -0.37 |
| EPS Diluted Total Ops | -0.41 | -0.38 | -0.20 | -0.91 | -0.37 |
| EPS Diluted Continuous Ops | -0.41 | -0.38 | -0.20 | -0.91 | -0.37 |
| EPS Diluted Before Non-Recurring Items | -0.41 | -0.38 | -0.20 | -0.34 | -0.37 |
| EBITDA(a) | $-53,282 | $-52,052 | $-32,330 | $-74,350 | $-46,169 |